Channels Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia
Duration of Untreated Psychosis, Treatment Response, and Resting State Functional Connectivity in Antipsychotic-Naïve First-Episode Psychosis Patients
Olanzapine induced DNA methylation changes support the dopamine hypothesis of psychosis
Acute Urinary Retention Following Low-Dose Risperidone in a Young Woman: A Case Report
Effectiveness and Adverse Effects of Risperidone in Children with Autism Spectrum Disorder in a Naturalistic Clinical Setting at a University Hospital in Oman
HIV-associated neurocognitive disorders
Clinical Characteristics of Over‐The‐Counter Drug Misusers in Psychiatric Practice in Japan: Comparison by Type of Drug Misused for the First Time
Sleep Disturbances, Psychosis Symptoms, and Suicidal Ideation in First Episode Psychosis: An Exploratory Mixed-Methods Study
Two Hospitalized Cases of Major Depressive Episodes With Comorbidities and Psychosocial Stressors: Case Reports
Sluggish cognitive tempo and its neurocognitive, social and emotive correlates: a systematic review of the current literature
An excitement building in the development of psychological treatments for schizophrenia
The new German evidence‐ and consensus‐based schizophrenia guideline
Structural Connectivity of Functionally Defined Episodic Memory Networks: A Large‐Scale Connectome–Behavior Study
Hydrogen Gas Therapy in Schizophrenia: Potential Neuroprotective Effects From an Animal Study
Alice in Wonderland and Ekbom Syndromes in a Bipolar I Manic Episode: A Case Report With Neuroimaging Findings
Effectiveness of Electroconvulsive Therapy in the Remission of Malignant Catatonia Associated With Schizophrenia: A Case Report
Biomarkers in Schizophrenia: Current Approaches and New Developments—A Literature Review
What does it take to make real‐world changes in schizophrenia care?
Towards an integrative and personalized care across the stages of schizophrenia spectrum disorders
Interventions in schizophrenia should be transdiagnostic, biologically informed, individualized, and disease modifying
The problem of recognition of clinical high‐risk states is hampering the prevention of schizophrenia
Insights into the origin of DNA methylation differences between monozygotic twins discordant for schizophrenia
Aerobic Exercise for Cognitive and Functional Enhancement in Schizophrenia: Evidence, Mechanisms, and Practical Recommendations
Quality of Life After Psychosis: Surviving Schizophrenia and Making a Full Emotional Recovery
Managing Recurrent Postictal Worsening of Psychosis in Clozapine-Treated Schizophrenia: A Case Report
